Choose your location:

Choose a Language

Contact us

Patient


9 results

Neuroscience

EACD 2020: How the use of functional assessments in clinical...
25 November 2020

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
Patient

Harnessing the power of real-world data for better, more tar...
09 October 2020

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
Group

Fulfilling our commitment to employees and mission to patien...
18 March 2020

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
Patient

Ipsen’s first clinical trial lay summary developed with pati...
18 October 2019

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
Innovation

#WeWontRest in using digital innovation to transform patient...
16 September 2019

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
Patient

COSMIC-021 trial
15 July 2019

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
Patient

Standby statement on lanreotide generic
29 April 2019

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

eng-ipsen-somatuline-standby-statement.pdf
See more
Neuroscience

LivingWithNETs.com awarded as Most valuable patient initiati...
19 March 2018

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
Patient

International Childhood Cancer Day, Ipsen mobilizes its team...
15 February 2018

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

See more
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023